Category: Thematic Seminar
Along with the enormous promise, there’s a lot of uncharted territory in the world of Microbiome. Separating what we believe we know and what we truly know about the microbiome is essential to directing research and commercialization efforts. From scoping microbiome-based modalities and sourcing new platforms to identifying regulatory strategies and insights there are a number of steps to development and commercialization from both the industry and startup point of view.
To explore the latest on this topic from the bench through clinical solutions Johnson and Johnson Innovation gathered a panel of trailblazers for a look at case studies and historical learnings to help better understand if this is truly the golden age of microorganisms.
What are the regulatory hurdles? Will the European laws affect the US market?
What are the concerns of the FDA and how are they viewing?
What are the clinical hurdles to be overcome?
What is the consumer path for microbiome based solutions?
How will products be marketed in terms of different regulations?
What are the thoughts on the intellectual property challenges?
How have startups thought about the regulatory approach and the IP concerns?
11:00 | Registration, Lunch & Networking
11:30 | Introductions & Panel Presentation
13:00 | Programme Close
$25 | General Public
$15 | Students
$35 | At the door
FLANDERS.BIO MEMBER BENEFIT: flanders.bio members receive a 50% reduction on the registration fee. Please contact us to obtain the reduction code.